CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, August 1, 2025 to report i ...

BRUSSELS -- European Commission President Ursula von der Leyen comfortably survived a vote of no confidence on Thursday as an ...

Given the number of times this has happened already, it should come as little surprise that we’re now faced with yet another ...

Carlene Pavlos, executive director of the Massachusetts Public Health Association, one of the plaintiffs, said in a statement ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The convergence of multiple crises—including the COVID-19 pandemic, geopolitical fragmentation, climate shocks, digital disruption, and economic precarity—has exposed the fragility and limitations of ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...

Three deaths reported nationally as Ohio's outbreak ends with 35 cases, while Texas accounts for 753 infections in the ...

Photo: Adobe Stock Despite the CDC’s move to kick the COVID-19 vaccine off recommended immunization schedules for children ...